Insider · CIK 0001666380
Ellen Rosenberg
officer
Files at FOLD (AMICUS THERAPEUTICS, INC.). First filing Nov 26, 2025, latest Nov 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $958k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | AMICUS THERAPEUTICS, INC. | $958k 95,621 shares | -18% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stock | -463,898 | $14.50 | $6.7M | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stockindirect: By Spouse | -15,000 | $14.50 | $218k | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -93,663 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -107,575 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -134,044 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -138,008 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -108,980 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -203,825 | - | - | 0 | Apr 27, 2026 |
| Jan 2, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -13,426 | $14.27 | $192k | 494,284 | Jan 6, 2026 |
| Jan 3, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -29,683 | $14.27 | $424k | 464,601 | Jan 6, 2026 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +25,000 | $6.10 | $153k | 532,710 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +11,000 | $5.13 | $56k | 543,710 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -36,000 | $10.06 | $362k | 507,710 | Nov 26, 2025 |
| Nov 25, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +36,000 | $5.13 | $185k | 543,710 | Nov 26, 2025 |
| Nov 25, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -36,000 | $10.00 | $360k | 507,710 | Nov 26, 2025 |
| Nov 26, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +23,621 | $5.13 | $121k | 531,331 | Nov 26, 2025 |
| Nov 26, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -23,621 | $10.00 | $236k | 507,710 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 0 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -11,000 | $0.00 | $0 | 59,621 | Nov 26, 2025 |
| Nov 25, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -36,000 | $0.00 | $0 | 23,621 | Nov 26, 2025 |
| Nov 26, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -23,621 | $0.00 | $0 | 0 | Nov 26, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +64,800 | $0.00 | $0 | 536,294 | Feb 13, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -28,584 | $9.57 | $274k | 507,710 | Feb 13, 2025 |
| Jan 2, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -6,442 | $9.31 | $60k | 377,777 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +112,495 | $0.00 | $0 | 490,272 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -15,397 | $9.41 | $145k | 474,875 | Jan 6, 2025 |
| Jan 4, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -3,381 | $9.41 | $32k | 471,494 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +203,825 | $0.00 | $0 | 203,825 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.